Aura Biosciences Valuation
| AURA Stock | USD 8.96 0.08 0.90% |
At this time, the firm appears to be undervalued. Aura Biosciences shows a prevailing Real Value of $13.41 per share. The current price of the firm is $8.96. Our model approximates the value of Aura Biosciences from analyzing the firm fundamentals such as Return On Equity of -0.51, current valuation of 288.28 M, and Shares Owned By Insiders of 5.00 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Aura Biosciences' valuation include:
Price Book 2.5395 | Enterprise Value 288.3 M | Enterprise Value Ebitda (5.68) |
Undervalued
Today
Please note that Aura Biosciences' price fluctuation is somewhat reliable at this time. Calculation of the real value of Aura Biosciences is based on 3 months time horizon. Increasing Aura Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Aura Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aura Stock. However, Aura Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.96 | Real 13.41 | Target 27.4 | Hype 8.88 |
The real value of Aura Stock, also known as its intrinsic value, is the underlying worth of Aura Biosciences Company, which is reflected in its stock price. It is based on Aura Biosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Aura Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Aura Biosciences helps investors to forecast how Aura stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aura Biosciences more accurately as focusing exclusively on Aura Biosciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Aura Biosciences' intrinsic value based on its ongoing forecasts of Aura Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Aura Biosciences' closest peers. If more than one evaluation category is relevant for Aura Biosciences we suggest using both methods to arrive at a better estimate.
Aura Biosciences Cash |
|
Aura Valuation Trend
Comparing Aura Biosciences' enterprise value against its market capitalization is a good way to estimate the value of Aura Biosciences uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Aura Biosciences Total Value Analysis
Aura Biosciences is presently projected to have valuation of 288.28 M with market capitalization of 443.57 M, debt of 19.56 M, and cash on hands of 122.13 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Aura Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
288.28 M | 443.57 M | 19.56 M | 122.13 M |
Aura Biosciences Asset Utilization
One of the ways to look at asset utilization of Aura is to check how much profit was generated for every dollar of assets it reports. Aura Biosciences shows a negative utilization of assets of -0.3 percent, losing $0.003022 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Aura Biosciences shows how discouraging it operates for each dollar spent on its assets.Aura Biosciences Ownership Allocation
Aura Biosciences holds a total of 49.95 Million outstanding shares. The majority of Aura Biosciences outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Aura Biosciences to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Aura Biosciences. Please pay attention to any change in the institutional holdings of Aura Biosciences as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Aura Biosciences Profitability Analysis
Net Loss for the year was (76.41 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Aura Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Aura Biosciences and how it compares across the competition.
About Aura Biosciences Valuation
The stock valuation mechanism determines Aura Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Aura Biosciences. We calculate exposure to Aura Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aura Biosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -1.3 M | -1.4 M |
Aura Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 39.6 M |
Aura Biosciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Aura Biosciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Aura we look at many different elements of the entity such as Aura's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Aura Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Aura Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Aura Biosciences' worth.Complementary Tools for Aura Stock analysis
When running Aura Biosciences' price analysis, check to measure Aura Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aura Biosciences is operating at the current time. Most of Aura Biosciences' value examination focuses on studying past and present price action to predict the probability of Aura Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aura Biosciences' price. Additionally, you may evaluate how the addition of Aura Biosciences to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |